There is no website visitor data available for this stock.
---
OCX FAQ
What was OncoCyte Corp’s price range in the past 12 months?
OncoCyte Corp lowest stock price was $2.08 and its highest was $7.41 in the past 12 months.
What is OncoCyte Corp’s market cap?
Currently, no data Available
When is OncoCyte Corp’s upcoming earnings report date?
OncoCyte Corp’s upcoming earnings report date is Apr 01, 2024 which is in 4 days.
How were OncoCyte Corp’s earnings last quarter?
OncoCyte Corp released its earnings results on Nov 09, 2023. The company reported -$0.81 earnings per share for the quarter, beating the consensus estimate of -$1.008 by $0.198.
How many shares outstanding does OncoCyte Corp have?
OncoCyte Corp has 8,260,762 shares outstanding.
What happened to OncoCyte Corp’s price movement after its last earnings report?
OncoCyte Corp reported an EPS of -$0.81 in its last earnings report, beating expectations of -$1.008. Following the earnings report the stock price went up 29.808%.
Which hedge fund is a major shareholder of OncoCyte Corp?
Among the largest hedge funds holding OncoCyte Corp’s share is Defender Capital, LLC.. It holds OncoCyte Corp’s shares valued at 179K.
OncoCyte Corp. is a pharmaceutical company. It is focused on the discovery, development and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. The company was founded in September 2009 and is headquartered in Alameda, CA.
Copying Michael Matson's trades and holding each position for 1 Year would result in 5.88% of your transactions generating a profit, with an average return of -69.15% per trade.